Targeted Medical Pharma, Inc. announced the promotion of David Silver, M.D., to the newly created position of president and chief operating officer, where he will oversee the company's expansion efforts and daily operations, while continuing his responsibilities as executive vice president of medical and scientific affairs.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0001 USD | -.--% | -.--% | -.--% |
1st Jan change | Capi. | |
---|---|---|
-.--% | 2.95K | |
+15.91% | 42.02B | |
+22.40% | 21.66B | |
+18.48% | 15.09B | |
+16.12% | 14.21B | |
+45.12% | 12.37B | |
-0.05% | 6.79B | |
-9.58% | 6.59B | |
-8.87% | 5.73B | |
+14.18% | 5.56B |
- Stock Market
- Equities
- TRGM Stock
- News Targeted Medical Pharma, Inc.
- Targeted Medical Pharma Promotes Dr. David Silver as President and Chief Operating Officer